GSK126 is a potent, highly selective EZH2 methyltransferase inhibitor.

Vorinostat is a synthetic hydroxamic acid derivative with antineoplastic activity.

CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor with IC50 values of 0.03 μM and 0.051μM for CBP and EP300 respectively in TR-FRET assay.

Entinostat is a synthetic benzamide derivative with potential antineoplastic activity.

Mocetinostat is a rationally designed, orally available, Class 1-selective, small molecule, 2-aminobenzamide HDAC inhibitor with potential antineoplastic activity.

Romidepsin is a bicyclic depsipeptide antibiotic isolated from the bacterium Chromobacterium violaceum with antineoplastic activity.

Tubastatin A HCl is a potent and selective HDAC6 inhibitor.

Givinostat is a potent HDAC inhibitor.